Magellan Bioanalytics Software Technology

Explore why we believe our technology increases likelihood of success in classifying patients, and examples of its use

Magellan has developed an AI software that is capable of matching the data output of today's mass spectrometers, allowing true OMICS analysis of the proteome, lipidome, and metabolome.  In addition, our software can integrate this data with other data types, such as sequencing.  Both of these innovations mark unprecedented leaps forward in potential ability to segment patients for trials, treatment, and patent extension purposes.

Explore how Magellan's new technology could help your drug program